Structures by: Şireci N.
Total: 15
1-(2-piperidinoethyl)benzimidazole
C14H19N3
Acta Crystallographica Section E (2004) 60, 5 o817-o819
a=6.3741(8)Å b=19.042(2)Å c=11.1476(14)Å
α=90° β=102.178(10)° γ=90°
1-(2-Morpholinoethhyl)benzimidazole
C13H17N3O
Acta Crystallographica Section E (2004) 60, 7 o1185-o1187
a=6.3949(7)Å b=8.7222(7)Å c=11.0868(12)Å
α=90° β=92.345(9)° γ=90°
5-Nitro-1-(2-piperidinoethyl)-1H-benzimidazole
C14H18N4O2
Acta Crystallographica Section E (2006) 62, 3 o922-o924
a=6.3202(2)Å b=10.1321(4)Å c=12.4362(5)Å
α=104.109(3)° β=103.953(2)° γ=102.546(2)°
3,3'-Bis(3-methylbut-2-enyl)-1,1'-propylenedibenzimidazolium dibromide monohydrate
C27H34N42,2Br,H2O
Acta Crystallographica Section E (2006) 62, 8 o3512-o3514
a=8.7777(4)Å b=12.0851(7)Å c=14.4078(7)Å
α=106.966(4)° β=96.868(4)° γ=104.747(4)°
1,3-Bis(4-methylbenzyl)benzimidazolium chloride monohydrate
C23H23N2,Cl,H2O
Acta Crystallographica Section E (2006) 62, 6 o2223-o2225
a=9.3636(8)Å b=9.4834(8)Å c=12.6509(12)Å
α=75.558(7)° β=82.798(7)° γ=73.581(7)°
3-Isopropyl-1-[2-(pyrrolidinium-1-yl)ethyl]benzimidazolium diodide
C16H25N32,2I
Acta Crystallographica Section E (2006) 62, 1 o185-o187
a=11.639(5)Å b=12.945(5)Å c=13.192(5)Å
α=90° β=94.349(5)° γ=90°
3,3'-Bis(cyclohexylmethyl)-1,1'-propylenedibenzimidazolium dibromide monohydrate
C31H42N42,2Br,H2O
Acta Crystallographica Section E (2006) 62, 8 o3184-o3186
a=9.2538(5)Å b=12.5925(8)Å c=15.4610(9)Å
α=105.049(5)° β=105.593(4)° γ=110.034(4)°
2-[(2-furylmethyl)sulfanyl]-1H-3,1-benzimidazol-3-ium chloride dihydrate
C12H11N2OS,Cl,2(H2O)
Acta Crystallographica Section E (2007) 63, 5 o2433-o2433
a=7.0649(6)Å b=21.5994(17)Å c=9.5520(7)Å
α=90° β=97.925(6)° γ=90°
1-cyclohexylmethyl-3-methyl-2-[(phenylimino)(sulfido)methyl]benzimidazolium
C22H25N3S
Acta Crystallographica Section E (2008) 64, 5 o809
a=11.0999(8)Å b=12.4601(7)Å c=15.0143(14)Å
α=90° β=99.007(7)° γ=90°
(<i>E</i>)-1,1-Bis[(<i>E</i>)-but-2-enyl]-3,3'-(propane-1,3-\ diyl)bis(1<i>H</i>-benzimidazol-3-ium) dibromide monohydrate
C25H30N42,2(Br),H2O
Acta Crystallographica Section E (2008) 64, 11 o2136-o2137
a=8.7989(9)Å b=11.1878(13)Å c=14.8813(14)Å
α=106.381(8)° β=96.490(8)° γ=106.227(8)°
1-(Prop-2-en-1-yl)-3-[(trimethylsilyl)methyl]benzimidazolium bromide monohydrate
C14H21N2Si,Br,H2O
Acta Crystallographica Section E (2010) 66, 9 o2393-o2394
a=8.9063(2)Å b=10.4720(2)Å c=10.9439(3)Å
α=66.542(4)° β=71.479(4)° γ=80.625(5)°
1-Benzyl-3-[(trimethylsilyl)methyl]benzimidazolium chloride monohydrate
C18H23N2Si,Cl,H2O
Acta Crystallographica Section E (2010) 66, 7 o1770-o1771
a=9.3592(7)Å b=10.9500(9)Å c=11.0522(8)Å
α=117.594(6)° β=103.295(6)° γ=92.094(6)°
1,3-Difurfurylbenzimidazolium chloride monohydrate
C17H15N2O2.Cl,H2O
Acta Crystallographica Section E (2009) 65, 8 o2037-o2038
a=9.0201(5)Å b=9.3135(5)Å c=11.2711(6)Å
α=66.778(4)° β=81.869(4)° γ=73.656(4)°
Dichloridobis[5-nitro-1-trimethylsilylmethyl-1<i>H</i>-benzimidazole- κ<i>N</i>^3^]cobalt(II) <i>N</i>,<i>N</i>-dimethylformamide solvate
C22H30Cl2CoN6O4Si2,C3H7NO
Acta Crystallographica Section E (2010) 66, 3 m253-m254
a=9.8982(4)Å b=11.6936(5)Å c=15.9293(6)Å
α=106.041(2)° β=107.408(2)° γ=99.040(3)°
1-{[Dimethyl(phenyl)silyl]methyl}-3-(2-phenylethyl)-1<i>H</i>-benzimidazol- 3-ium bromide monohydrate
C24H27N2Si,Br,H2O
Acta Crystallographica Section E (2012) 68, 9 o2718-o2719
a=15.1750(11)Å b=8.9097(6)Å c=17.9440(14)Å
α=90° β=96.235(6)° γ=90°